# FDA WARNING_LETTER - Devalingam Mahalingam, M.D., Ph.D. - October 18, 2024

Source: https://www.globalkeysolutions.net/records/warning_letter/devalingam-mahalingam-md-phd/206163ed-e4e0-40bc-87b1-d4d26adcc8fc

> FDA WARNING_LETTER for Devalingam Mahalingam, M.D., Ph.D. on October 18, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Devalingam Mahalingam, M.D., Ph.D.
- Inspection Date: 2024-10-18
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Officers

- [Devalingam Mahalingam](https://www.globalkeysolutions.net/people/devalingam-mahalingam/407c72f5-3f14-49b4-9103-ab02182ee969)
- [Brittany L. Garr-Colón](https://www.globalkeysolutions.net/people/brittany-l-garr-colon/8189d67e-dc7d-4ff4-8a99-82c18d4b4716)
- [Director ](https://www.globalkeysolutions.net/people/david-c-burrow/ad3d9e72-84f5-464c-8760-0f55d2fd7ca6)

Company: https://www.globalkeysolutions.net/companies/devalingam-mahalingam-md-phd/c4aa9219-b3c2-4842-a24f-cd02d1b4c5ad

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c